HRT and Peptides: What Your Doctor Isn't Telling You

If you're in perimenopause or menopause and you've talked to your doctor about hormone replacement therapy, you've covered one piece of the puzzle. HRT replaces the estrogen and progesterone your body is producing less of — and for many women, it's transformative for hot flashes, night sweats, vaginal dryness, bone density, and mood.

But here's what most physicians don't mention: estrogen and progesterone are not the only hormonal systems declining during this transition. Growth hormone output drops. Collagen production crashes. Mitochondrial function declines. Gut barrier integrity weakens. Immune regulation shifts. These are parallel axes — and HRT, no matter how well-optimized, does not address them.

Peptides do.

What HRT Does — and What It Doesn't

Hormone replacement therapy is designed to replace estrogen and progesterone — the two hormones whose withdrawal drives the hallmark symptoms of menopause. When initiated close to menopause onset (the "window of opportunity"), well-individualized HRT addresses the vasomotor symptoms (hot flashes, night sweats), urogenital atrophy, accelerated bone loss, and some of the mood disruption associated with hormonal decline.

This is significant, and for women who are candidates, HRT remains one of the most impactful interventions available. A 2026 review by Lephart in the journal Life documented HRT's effects on skin, bone, and cardiovascular biomarkers, while acknowledging the historical hesitancy that followed the Women's Health Initiative findings.

But HRT has a defined scope. It does not:

• Restore growth hormone pulsing — GH output declines approximately 14% per decade after age 30, contributing to changes in body composition, sleep quality, skin elasticity, and energy
• Reverse collagen loss — women lose approximately 30% of their collagen in the first 5 years after menopause, a process estrogen replacement only partially slows
• Repair gut barrier function — estrogen decline affects gut permeability and microbiome diversity, contributing to the increased IBS and digestive issues many women experience in perimenopause
• Modulate immune dysregulation — the shift in immune function during menopause (80% of autoimmune patients are female) operates through pathways distinct from sex hormones
• Support mitochondrial energy production — NAD+ depletion accelerates during perimenopause, contributing to the fatigue that estrogen replacement alone doesn't fully resolve

This is where peptides enter the conversation — not as replacements for HRT, but as targeted interventions for the systems that estrogen and progesterone don't reach.

The Six Axes Peptides Address

1. Growth Hormone & Body Composition

Growth hormone secretagogues like CJC-1295/Ipamorelin restore the natural pulsatile release of GH that declines with age. For women in perimenopause and menopause, this translates to improved sleep architecture, better body composition (particularly reduced visceral fat), improved skin elasticity, and enhanced recovery from exercise.

Tesamorelin — the only growth hormone peptide with FDA approval — specifically targets visceral abdominal fat, which is the number one body composition complaint during the menopausal transition. This isn't vanity — visceral fat is metabolically active tissue that increases cardiovascular risk, insulin resistance, and systemic inflammation.

2. Collagen & Skin Renewal

The 30% collagen loss in the first five years post-menopause is driven by estrogen decline, but HRT only partially slows this process — it doesn't reverse it. GHK-Cu (copper peptide) is a naturally occurring tripeptide that directly stimulates collagen I and III synthesis, promotes wound healing, and supports hair growth. Three new randomized controlled trials were initiated in 2025 for GHK-Cu in wound healing and hair regrowth.

Glutathione, the body's master antioxidant, depletes rapidly during menopause — a major driver of visible aging, hyperpigmentation, and oxidative damage. Supplemental glutathione supports skin brightening and provides the antioxidant protection that estrogen previously helped maintain.

3. Gut Barrier & Immune Modulation

IBS is twice as common in women as men, and symptoms frequently worsen during perimenopause as estrogen's protective effects on gut barrier integrity decline. BPC-157, the most extensively studied healing peptide, has over 180 preclinical publications and a pilot study showing 10 of 12 women with interstitial cystitis achieved 80–100% symptom resolution.

For autoimmune conditions — which disproportionately affect women (80% of autoimmune patients are female) — Thymosin Alpha-1 and KPV offer immune modulation through pathways entirely distinct from sex hormones. These are systems that HRT simply cannot reach.

4. Sleep & Mood

Perimenopause insomnia is one of the most commonly reported symptoms — and one of the most disruptive. Estrogen decline directly affects neurotransmitter systems involved in sleep regulation. While HRT can help with night sweats that fragment sleep, it doesn't always resolve the underlying sleep architecture disruption.

DSIP (Delta Sleep-Inducing Peptide) promotes slow-wave sleep — the deep, restorative phase. CJC-1295/Ipamorelin, taken before bed, enhances the natural nighttime growth hormone pulse that supports both sleep quality and recovery. Selank, an anxiolytic peptide that modulates GABA and serotonin without sedation or dependence risk, addresses the anxiety component that often accompanies perimenopausal sleep disruption.

5. Cellular Energy & Longevity

NAD+ is the foundational molecule for cellular energy production, and it depletes significantly during perimenopause. This contributes to the crushing fatigue many women describe — the kind that doesn't resolve with better sleep or more coffee. NAD+ supplementation supports mitochondrial function, DNA repair, and metabolic health at the cellular level.

SS-31 (elamipretide) targets mitochondria directly, stabilizing the inner mitochondrial membrane and improving energy output. Epitalon supports telomere maintenance. These peptides operate on the cellular aging pathways that accelerate during the menopausal transition.

6. Sexual Wellness

PT-141 (bremelanotide, brand name Vyleesi) is the only peptide with an FDA-approved indication specifically for women — it treats hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike flibanserin (Addyi), which requires daily use, PT-141 is used on-demand and works through melanocortin receptors in the brain rather than serotonin pathways.

For women in menopause, Kisspeptin-10 — a key upstream regulator of the HPG axis — is being researched as a potential tool for hormonal regulation beyond what HRT alone provides. A 2026 review in Comprehensive Physiology described kisspeptin neurons as an integrative hub connecting the HPO, HPT, and HPA axes during perimenopause.

Why Your Doctor Probably Hasn't Mentioned This

Peptide therapy isn't covered in most medical school curricula. Physicians learn about estrogen, progesterone, thyroid hormones, insulin, and cortisol — the classic endocrine system. Peptides like BPC-157, GHK-Cu, and CJC-1295 exist in a space between pharmaceutical drugs and nutraceuticals that most medical training doesn't address.

Additionally, the regulatory turbulence of the past three years — the 2023 Category 2 restrictions, the 2026 reclassification, the upcoming PCAC review — has made many conventional physicians cautious about recommending therapies whose legal status has been in flux.

Functional medicine, integrative medicine, and anti-aging practitioners are more likely to be familiar with peptide protocols. If your current provider isn't knowledgeable about peptides, that doesn't mean they're wrong about HRT — it means the two fields haven't fully converged yet.

Getting Started

If you're interested in exploring peptides alongside your existing HRT protocol (or as a standalone approach if you're not on HRT), start here:

1. Take the quiz — our 2-minute peptide quiz matches you to recommendations based on your life stage, symptoms, and preferences
2. Read the profiles — every peptide on this site has a detailed profile with mechanism of action, evidence strength, women-specific considerations, and vendor links
3. Find a provider — consult with a healthcare provider familiar with peptide therapy before starting any protocol
4. Source carefully — use verified suppliers with third-party COAs and proper cold-chain shipping

Frequently Asked Questions

Related Reading